Evidence map›Paper›PMID 35215278›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Identification of Antibacterial Peptide Candidates Encrypted in Stress-Related and Metabolic

Maria Fernanda da Silva Santos, Cyntia Silva Freitas, Giovani Carlo Verissimo da Costa, Patricia Ribeiro Pereira, Vania Margaret Flosi Paschoalin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Advances and perspectives for antimicrobial peptide and combinatory therapies.Frontiers in bioengineering and biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maria Fernanda da Silva SantosChemistry Institute, Federal University of Rio de Janeiro, Avenida Athos da Silveira Ramos 149, Cidade Universitaria, Rio de Janeiro 21941-909, Brazil.
Cyntia Silva FreitasChemistry Institute, Federal University of Rio de Janeiro, Avenida Athos da Silveira Ramos 149, Cidade Universitaria, Rio de Janeiro 21941-909, Brazil.
Giovani Carlo Verissimo da CostaNova Friburgo Health Institute, Fluminense Federal University, Nova Friburgo 28625-650, Brazil.ORCID 0000-0003-2721-0238
Patricia Ribeiro PereiraChemistry Institute, Federal University of Rio de Janeiro, Avenida Athos da Silveira Ramos 149, Cidade Universitaria, Rio de Janeiro 21941-909, Brazil.ORCID 0000-0002-9008-9904
Vania Margaret Flosi PaschoalinChemistry Institute, Federal University of Rio de Janeiro, Avenida Athos da Silveira Ramos 149, Cidade Universitaria, Rio de Janeiro 21941-909, Brazil.ORCID 0000-0001-6093-134X
Universidade Federal do Rio de Janeiro · BRUniversidade Federal Fluminense · BR

Funding

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/202.598/2016, E-26/202.459/2019, E-26/202.860/2016, E-26/202.815/2018, E-26/203.167/2019National Council for Scientific and Technological Development 146837/2019-3
6 · The paper itself

Abstract

The protein-rich nature of

Indexed as

antimicrobial peptidesbaker’s yeastbiomass autolysatefood-grade pharmaceuticalsFPLCin silico screeningnano-LC-MS/MS

Identifiers

PMID35215278
PMCPMC8877035
OpenAlexW4210765336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.